The Goizueta Foundation has pledged $ 50 million to Emory University to create the Goizueta Institute @Emory Brain Health, renaming the landmark initiative announced in May 2021 to Emory Brain Health Personalized Medicine Institute.
Led by Emory’s world-class brain health clinical and research teams, the Goizueta Institute @Emory Brain Health will leverage the power of large-scale data collection and analysis with patients and the healthcare community. health care to predict, prevent, diagnose and treat diseases of the brain.
“Emory has been a leader in the development of science and technology for the prevention and treatment of diseases of the brain. The Goizueta Foundation is proud to help integrate these innovations into clinical practice to promote healthy aging, ”said Olga Goizueta Rawls, Chairman of the Board and CEO of the Goizueta Foundation.
“The Goizueta Institute @Emory Brain Health will shape the future of our search for solutions to elusive brain diseases,” said Gregory L. Fenves, president of Emory University. “Neurodegenerative diseases, for too long, have been viewed as hopeless, just as cancer once was. But with this significant investment, Emory will deepen its focus on research and personalized and innovative patient care. I am grateful to the Goizueta Foundation for their visionary support, which will allow Emory to continue to play a leading role in solving one of the greatest health challenges of our time.
Over the past decade, the philanthropic support of the Goizueta Foundation has been instrumental in making Goizueta Alzheimer’s Disease Research Center and Emory Brain Health Center globally recognized leaders.
“We are deeply honored to receive this transformational grant from the Goizueta Foundation for this exciting new initiative,” said Allan Levey, MD, PhD, Founding Director of the Goizueta Institute @Emory Brain Health and Professor of Neurology at the Faculty of Medicine at the ‘Emory University. .
According to Levey, discovering and accelerating ways to educate preventive medicine and create personalized treatment strategies to ensure that medications, procedures and lifestyle interventions are effective for each patient are critical areas for the patient. new institute.
“This grant will provide fundamental support to increase our understanding of the biological, medical and lifestyle factors affecting brain health and disease and promote new research approaches to improve patient care and ultimately of account, prevent common brain diseases, ”said Levey.
Converging research indicates that many neurological and psychiatric conditions share an early stage – starting long before symptoms appear – when brain changes go undetected. This pre-symptomatic period offers great opportunities for disease prediction and prevention, but researchers must first determine why some people develop symptoms while others do not. Genetics, education, diet, social determinants of health, lifestyle, and other factors play common roles, which means studying brain disease and providing care in silos keep disease prediction out of reach.
“This generous grant will combine Emory’s strengths in clinical and discovery neuroscience to fuel the pioneering efforts of the Goizueta Institute @Emory Brain Health to develop a new approach to data-driven medicine. It will advance our understanding across the spectrum of brain health and ultimately transform the way we prevent and treat brain disease to improve lives and give hope, ”said Jonathan S. Lewin, MD, executive vice president of healthcare and CEO of Emory Healthcare. .
Key goals of the new Goizueta @Emory Brain Health Institute include:
1) Advance research to inform clinical care by standardizing assessments of brain function for brain diseases with common genetic symptoms and causes.
2) Establish a repository of biological samples to fuel the development and application of next generation biomarkers.
3) Develop a data technology platform to integrate clinical and research data enabling advanced analyzes.
4) Identify and diagnose brain disease at the earliest possible stage, optimize treatment and ultimately prevent disease.
The first plans of the Goizueta Institute @Emory Brain Health are to work collaboratively with teams in several fields, including neurology, psychiatry, primary care and sleep medicine. The goal will be to recruit participants and obtain their consent to collect data over a six-year period from the more than 50,000 unique patients seen each year at the Emory Brain Health Center.
Levey and colleagues say that with the announcement of breakthrough treatments for Alzheimer’s disease in the works, the timing of Goizueta Institute @Emory Brain Health is optimal. The Goizueta Institute @Emory Brain Health will initially focus on personalized medicine to prevent, diagnose and treat Alzheimer’s disease, Parkinson’s disease, ALS, epilepsy, stroke and depression.
Since 2014, the Goizueta Foundation has invested more than $ 54 million in Emory Brain Health’s pioneering efforts to improve patients’ lives and better understand neurodegenerative diseases. This grant brings that total to over $ 100 million.
Levey is internationally recognized for his work on neurodegenerative diseases and is the Goizueta Foundation Alzheimer’s Research Chair, Professor Betty Gage Holland and President and Director of the Goizueta Alzheimer’s Research Center at Emory.
# # #
About Brain Health at Emory University
As one of the nation’s leading research universities, Emory University is a leader in neuroscience education, discovery and patient care. Academics, scientists, physicians and clinicians from across the university collaborate to advance knowledge associated with the brain and brain health. The Emory Brain Health Center combines neurology, neurosurgery, psychiatry and behavioral sciences, rehabilitation medicine and sleep medicine in a unique integrated approach. Emory researchers predict, prevent, treat and cure diseases and disorders of the brain and tackle the growing global crisis associated with some of the most common. Additionally, Emory’s neuroethics program explores the evolving ethical, legal and social impact of neuroscience. Emory’s multidisciplinary approach transforms the global understanding of the brain’s vast frontiers, harnessing imagination and discovery to meet the challenges of the 21st century.